Three real Google Ads engagements for peptide brands, broken down month by month — the starting conditions, what was rebuilt, and the actual ROAS and revenue numbers behind each one.
Every agency claims results. Almost none show the actual numbers behind them — the starting point, the monthly progression, the specific levers that were pulled, and what the account looked like before anyone touched it. In a category as scrutinized as peptides, that gap matters more than usual, because “we get great ROAS” means very little if you can’t see whether the account stayed compliant while getting there.
This article walks through three real Google Ads engagements for peptide brands: the starting conditions, what was actually rebuilt, and the month-by-month numbers. No composite examples, no rounded-up estimates — these are the same case studies published on our site, broken down here in more depth than a case study page format usually allows.
If you’re evaluating whether a specialist Google Ads agency for peptide brands is worth the investment, this is what the work actually looks like.
In a typical e-commerce vertical, a strong ROAS number is a strong ROAS number — the path to get there is relatively standard. In the peptide category, the number only tells half the story. The more important question is how that number was achieved: whether the account stayed compliant while scaling, whether the growth was structural (and therefore durable) or a short-term spike from aggressive bidding, and whether the brand still owns a clean, sustainable account at the end of the engagement.
That’s why each case study below includes not just the outcome, but the account health context — disapproval rates, policy flags, and structural decisions — alongside the revenue numbers. If an agency shows you ROAS without any of that context, ask for it. It’s the difference between a number and a sustainable growth system.
This U.S. peptide brand had genuine product-market fit and a loyal biohacking community, but their Google Ads account had flatlined at $8,000 per month for six straight months. The account was running a single Search campaign with one bidding strategy — no Shopping presence, no Display, no Performance Max. Target CPA was set so conservatively that the account was chronically under-delivering against its own daily budget. There was nowhere left for this structure to grow.
The single-campaign structure was dismantled entirely and rebuilt as a full-funnel system:
Shopping became the account’s top revenue driver within 60 days of launch — a channel that had sat completely dormant for the brand’s entire paid media history. The client’s own words: “We’d been stuck at the same number for half a year. Six months in with Oney and we were at ten times that.”
This brand had never run paid search at all. Zero account history, a strong organic community, but no paid acquisition infrastructure. Launching Google Ads meant building compliance into the account structure from the very first campaign — core product terms in this category flag frequently, Smart Bidding can’t function without conversion data, and the brand’s landing pages weren’t built to convert paid traffic in the first place.
The account reached positive ROAS by the end of month two — ahead of the typical 90-day target for a cold-start restricted-category account — and recorded zero policy disapprovals after initial setup. That clean account history compounded: it protected delivery, reduced CPCs over time, and unlocked scale that a flagged account simply can’t access. In the brand’s words: “We had no idea paid search could work for our niche. Within two months we were profitable — and it’s been growing every month since.”
Following a brand acquisition, this peptides company needed to rebuild its entire Google Ads presence from scratch — inside a tightly regulated niche, with zero runway for missteps. The challenge wasn’t just recreating campaigns; it was replicating a high-performing structure while operating in a category where disapprovals stall momentum fast and one policy flag can affect the whole account.
Zero to five figures in monthly spend in under three months, without breaking efficiency, and consistent policy compliance across the full six-month scaling period — no account-level flags at any point. As the client put it: “We were worried the transition would slow us down. Instead, we grew faster than ever. The structure, strategy, and scale were flawless.”
Read side by side, these three engagements look different on the surface — a plateau break, a cold start, and a full account rebuild — but the underlying pattern is identical, and it’s the same pattern we’d point to if you asked us how to scale a peptide brand with paid ads in any context:
Structure before scale. In every case, the first move was fixing the campaign architecture — not increasing budget. A peptide brand with a broken account structure will not out-spend its way to a good ROAS; it will just get flagged faster.
Compliance is built in, not bolted on. None of these accounts treated policy compliance as a separate workstream from performance. Ad copy, landing pages, and account structure were all reviewed against Google’s healthcare advertising policies from the beginning — which is the actual reason all three accounts avoided account-level suspension while scaling.
Manual bidding before Smart Bidding. Every cold-start or restructured account went through a deliberate Manual CPC phase to build real conversion data before migrating to automated bidding strategies. Skipping this step is the single most common mistake we see peptide brands (and their previous agencies) make.
Shopping and full-funnel structure unlock growth that Search alone can’t. In two of the three case studies, adding Google Shopping and upper-funnel Display/remarketing layers was the single highest-leverage move — not a bigger budget on the same single campaign.
Growth compounds instead of spiking. None of these accounts show a hockey-stick month followed by a crash. Every one shows steady, month-over-month compounding — which is what a durable account looks like versus one that’s about to get flagged.
The account is treated as a long-term asset, not a short-term spend target. Every decision in these three engagements — the negative keyword lists, the manual bidding phase, the proactive ad copy review — trades a small amount of short-term speed for long-term account health. That trade-off is the actual differentiator between agencies that can sustain results in this category for years and agencies that can produce one good quarter before an account gets flagged and the relationship ends.
Case studies are marketing material, and it’s worth knowing how to read them critically — even the ones published by the agency you’re considering hiring.
Ask what “ROAS” actually includes. Some agencies report ROAS on ad spend only; others blend in discount codes, returns, or attribution windows that flatter the number. Ask directly: is this platform-reported ROAS, and does it account for returns and refunds?
Ask about the timeline that isn’t shown. A case study showing Month 1 through Month 6 doesn’t tell you what happened in Month 7 if the engagement continued, or why it ended if it didn’t. Ask what happened after the case study’s published window.
Ask whether the account is still active and compliant today. A strong six-month result that was followed by a suspension in month eight is a very different story than one that’s been running cleanly for two years. All three case studies above are still live, active accounts as of this writing — that’s a detail worth confirming for any agency’s case studies, not assuming.
Ask for the starting conditions, not just the ending numbers. “We got 4x ROAS” means something completely different for a brand that started at 3.5x ROAS than for one that started with a suspended account and no conversion history. Every case study above states the starting point explicitly for exactly this reason.
Be skeptical of case studies with no account health context. If a case study shows only revenue and ROAS with zero mention of disapprovals, policy flags, or compliance approach, either the agency doesn’t track that data, or they’re choosing not to show it. Neither is a good sign for a category this regulated.
None of this means case studies are untrustworthy — it means the specific, verifiable details matter more here than the headline multiplier. That’s exactly why each case study above links through to the full published version, where you can see the complete ad copy examples, the funnel structure, and the client quotes in context.
When you’re vetting a Google Ads agency for peptide brands, ask to see this level of detail. Not just a final ROAS figure, but the month-by-month trajectory, the specific structural changes made, and — critically — the account health data alongside the performance data. An agency that can show you a clean disapproval history next to a growth curve is showing you something far more valuable than a headline number: evidence that the growth is durable.
If you’re currently stuck at a plateau, running a cold-start account, or rebuilding after an acquisition or a previous agency’s mistakes, these three situations likely map closely to where you are right now. The playbook is consistent: fix the structure, build compliance in from day one, migrate bidding strategies deliberately, and layer in Shopping and remarketing once the foundation is solid.
It’s also worth noting what these case studies don’t show: a brand that tried to run peptide ads on Meta alongside Google and got caught in the split-focus trap of managing two very different policy regimes at once. All three of these engagements were built as Google Ads–only accounts from the start, which is part of why the compliance posture stayed clean — the team was solving one platform’s policy landscape deeply, not two platforms shallowly.
Want to see what this could look like for your account?
We’ll review your current Google Ads setup (or your launch plan, if you’re starting cold) and tell you honestly what we see — including what we’d do differently and roughly what a realistic timeline to results looks like for your specific situation.
Or email directly: sveta@oney.studio
Oney Studio is a Google Ads specialist agency for peptide and research chemical brands. Every case study on this page reflects verified account results — figures as published on our site, current as of this writing.
Get a free 30-minute audit of your Google Ads or Meta Ads account. We’ll review compliance, structure, and growth opportunities — no strings attached.
Book a Free Audit